Schedule 14. 1.3.2 contains a true and complete listing of the following Assigned Contracts to which the Xxxxxx Cogen Company is a party (the “Xxxxxx Xxxxx Company Contracts”) or to which any Seller is a party (provided, that for purposes of this Section 14.1.3.2 the definition of Assigned Fuel Retail Contracts for purposes of defining the Assigned Contracts shall include only the Jobber Agreements and the Included Fuel Retail Assigned Contracts):
Schedule 14. 18.1 contains (i) a list of all material insurance policies (listing the respective amount insured) maintained by or on behalf of an EMP Group Company (the “Insurance Policies”) and (ii) all claims that have been asserted by EMP Group Companies under the Insurance Policies in the twenty-four (24) months prior to the Signing Date in an amount in excess of EUR 75,000.00 (in words: Euro seventy-five thousand) in the individual case.
Schedule 14. 25.1 sets forth a list of (i) the 78 largest suppliers of products or services to the Business as measured by Euro value for the twelve (12)-month period ended on 31 July 2018 (such suppliers collectively, the “Major Suppliers”’) and (ii) the six largest licensors to the Business as measured by Euro value for the twelve (12)-month period ended on 31 July 2018 (such licensors collectively, the “Major Licensors”).
Schedule 14. 1 contains a correct and complete list of all agreements, plans, programs and other commitments of each Target Group Company, whether of an individual or collective labor law nature and including commitments based on works custom (betriebliche Übung), regarding employee benefits of any kind, except for the Pension Plans, such as anniversary, holiday, or jubilee or other leave payments, bonuses, commissions, profit participation or other variable remuneration elements, stock options, stock appreciation rights or similar rights, deferred compensation, early retirement, severance pay, employee health or welfare benefit plan, car allowance, perquisite or any other fixed or variable remuneration elements (the “Employee Benefit Plans”). Such list correctly states the legal basis for the Employee Benefit Plans and the nature and dates of the respective agreements or other commitments.
Schedule 14. 3 contains a complete and correct list and description of all pension obligations and commitments (including policy number and contract partner) of each Target Group Company towards, and any pension entitlements of the Employees and their dependents regarding old age and occupational disability pensions under or in connection with, individual pension promises (Direktzusagen), direct insurances (Direktversicherungen), pension funds (Pensionsfonds), pension pools (Pensionskassen), relief funds (Unterstützungs¬xxxxxx), reinsurance coverages (Kapitallebens- und Rückdeckungs¬versicherungen), general pension schemes (Gesamtversorgungs¬zusagen und –ordnungen) and all other company retirement or pension schemes (betriebliche Altersversorgungen), in each case as existing as of the Signing Date (the “Pension Plans”).
Schedule 14. 1 to the Disclosure Letter contains a list of the material insurance policies in which the Group Companies are the policyholder (the “Insurance Policies”), all of which are in force at the date of the Agreement.
Schedule 14. 1(i) contains a complete and accurate list of insurance contracts with the Company, containing details in each case of the scope of insurance and the cover amount. The insurance policies are in force and have not been terminated. There are no circumstances which jeopardize the validity of the insurance cover; in particular, the Company is not in arrears with any premium payments. With the exception of the cases set out in Schedule 14.1(ii), as at the date hereof no pending insured events of loss or insured claims have occurred or been reported to the Company since the Reference Date.
Schedule 14. 2.1 sets forth a list of Humacyte Patents as of the Effective Date, and accurately indicates (a) whether any such Patent is solely owned by Humacyte, (b) whether any such Patent is jointly owned by Humacyte with another Person, and the name of any such other Person, and (c) whether any such Patent is the subject of a Humacyte In-License, and the date of, parties to and title of any such Humacyte In-License.
Schedule 14. 7.2 hereto contains a complete and correct list of all lease agreements concerning real property, including the date of each lease agreement and of any amendments thereto. To the best knowledge of Sellers, the lease agreements set forth in Schedule 14.7.2 hereto are valid, in full force and effect and binding until the end of their term. The Company enjoys undisturbed possession of all leased space under all of its real property leases, to the extent not subleased, as set forth in Section 14.7.2(i) below. The Company has paid all advances and granted all security it is required to grant under such leases when due. The Company is not in default of such leases and no event has occurred which with the giving of notice or the passage of time or both would constitute a default by the Company under any of such leases. With respect to the real property leases set forth in Schedule 14.7.2 hereto:
Schedule 14. 9.9 hereto contains a complete and correct list of certain important (written or oral) contracts of the Company, to the extent such contracts are not reflected in the Annual Accounts 2002 or the Interim Accounts (hereinafter referred to collectively as the "Material Contracts"):
